Administration Shares Regulatory Priorities for 2020
The Trump administration’s health care regulatory priorities for 2020 have been outlined by the Office of Management and Budget in a newly released “Statement of Regulatory Priorities for Fiscal Year 2020.”
The statement, an annual OMB document, organizes the priorities as follows:
- Facilitating patient-centered markets
- Fixing health care financing through protecting private insurance and Medicare
- Fixing health care financing through reforming the individual market
- Fixing health care financing through making the ACA and Medicaid fiscally sustainable
- Bringing value to health care through price and quality transparency
- Bringing value to health care through patient-centered health IT
- Bringing value to health care through deregulation, especially for coordinated care
- Bringing value to health care through tackling the high cost of prescription drugs
- Bringing value to health care through accelerated drug and device approval and reimbursement
- Promoting health and protecting life
- Addressing impactable health challenges: kidney health
- Addressing impactable health challenges: combatting the opioid crisis
- Protecting conscience and life at all stages
- Reducing the disease and death associated with tobacco use
- Promoting independence
- Returning TANF to promoting work, marriage and family
- Supporting adoption
- Empowering Americans to improve their nutrition
- Promoting flexibility for states, grantees, and regulated entities
Learn more about the regulatory directions the administration intends to take for the rest of its 2020 fiscal year in the newly released “Statement of Regulatory Priorities for Fiscal Year 2020.” Go here to see the complete list of regulations that the Department of Health and Human Services intends to pursue in FY 2020, including 55 by the Centers for Medicare & Medicaid Services (CMS).
